Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Luke R Smart, MD |
Comprehensive care for infants |
American Academy of Pediatrics |
Smart, Luke, AAP |
7/1/21-6/30/22 |
$2,000 |
Lisa M Littner LISW-S |
An online, family-based wellne |
The Hemophilia Alliance Foundation |
HAF-Littner |
4/1/22-3/31/23 |
$3,500 |
Adrienne Hammill, MD |
Brain Vascular Malformation Co |
National Institutes of Health (NIH)/The Regents of the Univ of California |
11573SC |
7/1/21-6/30/22 |
$3,975 |
Luke R Smart, MD |
Hydroxyurea Pharmacokinetics i |
American Society of Hematology/Rhode Island Hospital |
7132047 |
11/1/21-10/31/22 |
$5,158 |
Omar Y. Niss, MD |
Genetic and Biologcal Determinants of Immune Thrombocyto |
Texas Children's Hospital |
McGann, Pat, TCH |
7/1/16-6/30/25 |
$6,250 |
Cristina Tarango, MD |
VERITAS-NEXTGEN: A new survey |
Indiana Hemophilia & Thrombosis Center |
IHTC |
8/10/21-8/9/26 |
$6,839 |
Eric Mullins, MD |
Assessment of the impact of an |
Cascade Hemophilia Consortium |
Mullins, E., CHC |
12/1/21-5/31/22 |
$7,500 |
Adrienne Hammill, MD |
Brain Vascular Malformation Co |
National Institutes of Health (NIH)/The Regents of the Univ of California |
11614sc |
7/1/21-6/30/22 |
$12,456 |
Cristina Tarango, MD |
ATHN Data Quality Counts Award |
American Thrombosis & Hemostatis Network |
433 |
9/1/21-8/31/22 |
$20,000 |
Russell Ware, MD-PHD |
An implementation toolkit for |
National Institutes of Health (NIH)/Global Health Uganda |
GHU-02-2021-01 |
6/7/21-5/31/22 |
$20,038 |
Cristina Tarango, MD |
Region V East Comprehensive Care Network for Bleeding D |
Maternal & Child Health Bureau/Hemophilia Foundation of Michigan |
H30MC24047 |
6/1/21-5/31/22 |
$22,000 |
Cristina Tarango, MD |
Community Counts: Public Health Surveillance for Bleedin |
Ctr for Disease Control and Prevention/Hemophilia Foundation of Michigan |
U27DD001155 |
9/30/21-9/29/22 |
$27,250 |
Lisa M Shook |
HRSA Central Region Thalassemi |
Health Resources & Services Admin/Ann & Robert H Lurie Children's Hospital |
901639-CCHMC |
6/1/22-5/31/23 |
$29,999 |
Bal Krishan Sharma, PHD |
T32 Training grant |
National Institutes of Health (NIH)/University of Cincinnati |
1017278 |
10/1/21-6/30/22 |
$55,291 |
Cristina Tarango, MD |
Hemophilia Inhibitor Preventio |
Health Resources & Services Admin/University of Pittsburgh |
AWD00002738 |
6/1/20-5/31/27 |
$56,428 |
Cristina Tarango, MD |
ATHN Transcends |
American Thrombosis & Hemostatis Network |
ATHN2020-TS-433-01 |
8/1/21-7/31/26 |
$68,500 |
Patrick McGann, MD-MS |
Hydroxyurea Pharmacokinetics i |
American Society of Hematology |
McGann_ASH |
7/1/21-6/30/22 |
$75,000 |
Katie M Seu, PHD |
Investigating the role of VPS4 |
National Institutes of Health (NIH)/University of Utah |
10055841-25 |
1/1/22-12/31/22 |
$75,000 |
Lisa M Shook |
Newborn Screening Systems Qual |
Health Resources & Services Admin/Association of Public Health Laboratorie |
56300-600-158-22-24 |
1/1/22-8/31/22 |
$100,000 |
Lisa M Shook |
Cincinnati Sickle Cell Project |
Ohio Department of Health |
03130011SK1320 |
7/1/21-6/30/22 |
$133,668 |
Omar Y. Niss, MD |
Community Health Workers and m |
Patient-Centered Outcome Research Inst./Children's Hospital of Philadelphia |
4261420324 |
3/1/22-2/28/23 |
$146,040 |
Luke R Smart, MD |
Sickle Cell Anemia, Splenic Pa |
National Institutes of Health (NIH) |
K23HL153763 |
7/1/21-6/30/22 |
$169,560 |
Cristina Tarango, MD |
Hemophilia and Thrombosis Center |
Hemophilia Foundation of Michigan |
Tarango, CHC,HFM |
6/1/21-5/31/22 |
$306,961 |
Eric Mullins, MD |
Mechanisms linking hemostatic |
National Institutes of Health (NIH) |
R01NS107258 |
3/1/22-2/28/23 |
$412,354 |
Theodosia A Kalfa, MDPHD |
The Role of Erythroblastic Isl |
National Institutes of Health (NIH) |
R01HL152099 |
4/1/22-3/31/23 |
$557,940 |
Russell Ware, MD-PHD |
Realizing Effectiveness Across Continents with Hydroxyur |
National Institutes of Health (NIH) |
U01HL133883 |
8/1/21-7/31/22 |
$675,820 |
Lisa M Shook |
Sickle Treatment and Outcomes |
Health Resources & Services Admin |
U1EMC27863 |
9/1/21-8/31/22 |
$900,000 |
Patrick McGann, MD-MS |
Maximizing Fetal Hemoglobin Responses to Hydroxyurea using Precision Medicine |
Doris Duke Charitable Foundation |
2017090 |
9/1/19-3/31/22 |
$972,791 |
Total Annual Grant Award Dollars |
$4,872,318 |